Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02945501 · ClinicalTrials.gov registry record · NA

Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep

A NA study of Sleep Deprivation and Mental Competency, sponsored by U.S. Army Medical Research and Development Command.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02945501: Recruiting NA study of Sleep Deprivation and Mental Competency, sponsored by U.S. Army Medical Research and Development Command.

NCT02945501 is a NA study of Sleep Deprivation and Mental Competency that is actively recruiting participants, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 40 participants, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02945501, a NA study of Sleep Deprivation and Mental Competency, is actively recruiting participants, sponsored by U.S. Army Medical Research and Development Command.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if the enhancement of electroencephalographic (EEG) slow-wave activity using transcranial electrical stimulation (TES) at Slow Oscillation (SO) frequency, during a restricted period of nocturnal sleep, enhances the restorative properties of that period of sleep and improves performance during a subsequent period of sleep deprivation.

Primary Outcome

Number of Participants With Abnormal Laboratory Values and/or Adverse Events That Are Related to Treatment. Vital signs (blood pressure, pulse, and temperature) will be recorded and abnormal values will be reported to PI who will determine if events meet criteria and definition of an unanticipated device effect (UADE).

Interventions

  • DEVICE NeuroConn DC Stimulator PLUS
  • DEVICE SHAM TES

Study Locations (1)

Maryland

  • Naval Medcical Research Center (NMRC) Clincal Trials Center - Bethesda

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2016-10-27
Est. Completion 2027-12
Phase NA

What NCT02945501 shows while recruiting

NCT02945501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 90-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (56% lower).

The record links to 2 conditions, with Sleep Deprivation appearing as the primary indexed condition, and to 2 interventions - of which NeuroConn DC Stimulator PLUS is the first listed.

NCT02945501 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02945501 about?

NCT02945501 is a clinical study titled "Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep". The purpose of this study is to determine if the enhancement of electroencephalographic (EEG) slow-wave activity using transcranial electrical stimulation (TES) at Slow Oscillation (SO) frequency, during a restricted period of nocturnal sleep, enhances the restorative properties of that period of sl...

What is the current status of trial NCT02945501?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2016-10-27. Estimated completion is 2027-12.

What conditions does trial NCT02945501 study?

This clinical trial studies the following conditions: Sleep Deprivation, Mental Competency.

What interventions are being tested in trial NCT02945501?

The interventions under investigation include: NeuroConn DC Stimulator PLUS (DEVICE), SHAM TES (DEVICE).

Who is sponsoring clinical trial NCT02945501?

This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02945501 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Deprivation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02945501's enrollment target sits among peer trials

40 26th of 34 higher than 9 of 34 other Sleep Deprivation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Deprivation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02945501, the US trial registry maintained by the National Library of Medicine. NCT02945501 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.